These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30347109)

  • 1. Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases.
    Schräder NHB; Duipmans JC; Molenbuur B; Wolff AP; Jonkman MF
    Br J Dermatol; 2019 Apr; 180(4):922-924. PubMed ID: 30347109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study.
    Schräder NHB; Duipmans JC; Renken RJ; Sörös P; Vermeulen KM; Bolling MC; Wolff AP
    PLoS One; 2022; 17(12):e0277512. PubMed ID: 36508401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.
    Chelliah MP; Zinn Z; Khuu P; Teng JMC
    Pediatr Dermatol; 2018 Jul; 35(4):e224-e227. PubMed ID: 29786144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study.
    Schräder NHB; Gorell ES; Stewart RE; Duipmans JC; Harris N; Perez VA; Tang JY; Wolff AP; Bolling MC
    Orphanet J Rare Dis; 2021 Sep; 16(1):377. PubMed ID: 34488820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cannabidiol (CBD) for the treatment of chronic pain.
    Urits I; Gress K; Charipova K; Habib K; Lee D; Lee C; Jung JW; Kassem H; Cornett E; Paladini A; Varrassi G; Kaye AD; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):463-477. PubMed ID: 33004159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.
    Lichtman AH; Lux EA; McQuade R; Rossetti S; Sanchez R; Sun W; Wright S; Kornyeyeva E; Fallon MT
    J Pain Symptom Manage; 2018 Feb; 55(2):179-188.e1. PubMed ID: 28923526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
    Rog DJ; Nurmikko TJ; Young CA
    Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral opioids in inflammatory pain.
    Watterson G; Howard R; Goldman A
    Arch Dis Child; 2004 Jul; 89(7):679-81. PubMed ID: 15210505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report.
    Pichler EM; Kawohl W; Seifritz E; Roser P
    Int J Psychiatry Med; 2019 Mar; 54(2):150-156. PubMed ID: 30058466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrous oxide for procedural analgesia at home in a child with epidermolysis bullosa.
    Ingelmo P; Wei A; Rivera G
    Paediatr Anaesth; 2017 Jul; 27(7):776-778. PubMed ID: 28497520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical considerations in medical cannabis administration and dosing.
    MacCallum CA; Russo EB
    Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study.
    Hartzell CJ; Szabova A; Collins AB; Morel AN; Mijatovic D; Goldschneider KR
    Pediatr Dermatol; 2024; 41(5):819-821. PubMed ID: 39049669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sativex for the management of multiple sclerosis symptoms.
    Perras C
    Issues Emerg Health Technol; 2005 Sep; (72):1-4. PubMed ID: 16317825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of topical morphine gel in epidermolysis bullosa wounds-A series of case studies.
    Snelson K; Downe A
    Int Wound J; 2023 Aug; 20(6):1954-1959. PubMed ID: 36517963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin as part of multimodal analgesia in a newborn with epidermolysis bullosa.
    Allegaert K; Naulaers G
    Paediatr Anaesth; 2010 Oct; 20(10):972-3. PubMed ID: 20849513
    [No Abstract]   [Full Text] [Related]  

  • 18. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.
    Wade DT; Makela P; Robson P; House H; Bateman C
    Mult Scler; 2004 Aug; 10(4):434-41. PubMed ID: 15327042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Hemp oil, CBD, and Marijuana Primer: Powerful Pain, Insomnia, and Anxiety-relieving Tools!
    Teitelbaum J
    Altern Ther Health Med; 2019 Jun; 25(S2):21-23. PubMed ID: 31202200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain management in epidermolysis bullosa.
    Goldschneider KR; Lucky AW
    Dermatol Clin; 2010 Apr; 28(2):273-82, ix. PubMed ID: 20447492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.